MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Delcath Systems Retained Earnings 2011-2026 | DCTH
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -529 M | -532 M | -505 M | -457 M | -421 M | - | -371 M | -344 M | -325 M | -279 M | -261 M | -247 M | -229 M | -199 M | -147 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -147 M | -532 M | -346 M |
Quarterly Retained Earnings Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -527 M | -528 M | -530 M | -532 M | -528 M | -530 M | -516 M | -505 M | -494 M | -474 M | -466 M | -457 M | -447 M | -439 M | -429 M | -421 M | -416 M | -409 M | -402 M | -395 M | -395 M | -395 M | -395 M | -371 M | -371 M | -371 M | -371 M | -344 M | -344 M | -344 M | -344 M | -325 M | -325 M | -325 M | -325 M | -279 M | -279 M | -279 M | -279 M | -261 M | -261 M | -261 M | -261 M | -247 M | -247 M | -247 M | -247 M | -229 M | -229 M | -229 M | -229 M | -199 M | -199 M | -199 M | -199 M | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -199 M | -532 M | -357 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-63.5 M | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Profound Medical Corp.
PROF
|
-130 M | $ 5.82 | 13.01 % | $ 180 M |  Canada |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Smith & Nephew plc
SNN
|
4.96 B | - | - | $ 23.8 B |  Britain |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
21.2 M | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.16 | 7.46 % | $ 1.31 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M | Canada |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.55 | 0.1 % | $ 735 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
-176 M | $ 6.42 | 1.58 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
IRadimed Corporation
IRMD
|
64.2 M | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.67 | -3.52 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 63.3 | 1.44 % | $ 3.45 B | Britain |
 |
InspireMD
NSPR
|
-302 M | $ 1.77 | -1.12 % | $ 114 M | Israel |
 |
LENSAR
LNSR
|
-143 M | $ 5.58 | 0.36 % | $ 64.3 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
238 M | $ 336.27 | 0.63 % | $ 13.1 B | USA |
 |
Medtronic PLC
MDT
|
31.5 B | $ 87.89 | 1.51 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 4.1 | -0.73 % | $ 606 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-374 M | $ 2.29 | -4.58 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Myomo
MYO
|
-119 M | $ 0.7 | -0.1 % | $ 29.3 M | USA |
 |
NanoVibronix
NAOV
|
-69.8 M | - | - | $ 1.08 M | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 51.41 | -1.27 % | $ 1.51 B | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 11.93 | 1.79 % | $ 472 M |  Curacao |